PRKCZ and cancer: In contrast, PRKCZ is mainly associated with cancer cell response to nutrient deprivation in intestinal tumorigenesis74, suggesting that, following osimertinib treatment, HCT-15 cells undergo metabolic adaptation to induce drug-resistance.